SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Obesity and Overweight. Fact Sheet No 311; http://www.who.int/mediacentre/factsheets/fs311/en/index.html Date last updated: March 2011. Date last accessed: May 5, 2011
  • 2
    Chen Y, Dales R, Krewski D, Breithaupt K. Increased effects of smoking and obesity on asthma among female Canadians: The national population health survey, 1994-1995. Am J Epidemiol 1999;150:255262.
  • 3
    Ronmark E, Andersson C, Nystrom L, Forsberg B, Jarvholm B, Lundback B. Obesity increases the risk of incident asthma among adults. Eur Respir J 2005;25:282288.
  • 4
    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007;175:661666.
  • 5
    Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495503.
  • 6
    Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101:22402247.
  • 7
    Camargo CA Jr , Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH et al. Body mass index and response to asthma therapy: Fluticasone propionate/salmeterol versus montelukast. J Asthma 2010;47:7682.
  • 8
    Camargo CA Jr , Sutherland ER, Bailey W, Castro M, Yancey SW, Emmett AH et al. Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans. Curr Med Res Opin 2010;26:16291635.
  • 9
    Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2009;123:13281334.
  • 10
    Nanji AA, Freeman JB. Relationship between body weight and total leukocyte count in morbid obesity. Am J Clin Pathol 1985;84:346347.
  • 11
    Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:21312135.
  • 12
    Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the third national health and nutrition examination survey. Atherosclerosis 2003;168:351358.
  • 13
    Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911919.
  • 14
    Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003;11:368372.
  • 15
    Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord 2000;24:13921395.
  • 16
    Pratley RE, Wilson C, Bogardus C. Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender. Obes Res 1995;3:563571.
  • 17
    Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218224.
  • 18
    Lessard A, Turcotte H, Cormier Y, Boulet LP. Obesity and asthma: A specific phenotype? Chest 2008;134:317323.
  • 19
    Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008;178:682687.
  • 20
    Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Erzurum SC et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011;127:1486,93.e2.
  • 21
    Farah CS, Kermode JA, Downie SR, Brown NJ, Hardaker KM, Berend N et al. Obesity is a determinant of asthma control, independent of inflammation and lung mechanics. Chest 2011;140:659666.
  • 22
    Meijer RJ, Kerstjens HA, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999;54:894899.
  • 23
    Broekema M, Volbeda F, Timens W, Dijkstra A, Lee NA, Lee JJ et al. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). Respir Med 2010;104:12541262.
  • 24
    Broekema M, ten Hacken NH, Volbeda F, Lodewijk ME, Hylkema MN, Postma DS et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009;180:11701178.
  • 25
    Kerstjens HA, Brand PL, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch chronic non-specific lung disease study group. N Engl J Med 1992;327:14131419.
  • 26
    van den Berge M, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, Postma DS. Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 2004;34:7176.
  • 27
    Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. work group on standardization of respiratory function tests. european community for coal and steel. official position of the european respiratory society. Rev Mal Respir 1994;11(Suppl. 3):540.
  • 28
    Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705710.
  • 29
    Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993;147:11261131.
  • 30
    Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: Identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875879.
  • 31
    Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384390.
  • 32
    Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183192.
  • 33
    Scott HA, Gibson PG, Garg ML, Wood LG. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011;38:594602.
  • 34
    Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:18211830.
  • 35
    Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004;172:18091814.
  • 36
    Baines KJ, Simpson JL, Wood LG, Scott RJ, Gibson PG. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011;60:160.
  • 37
    Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994;18:207212.
  • 38
    Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913917.
  • 39
    Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nat Med 1996;2:949950.
  • 40
    Dixon AE, Shade DM, Cohen RI, Skloot GS, Holbrook JT, Smith LJ et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006;43:553558.